ISMP conducting survey on tall man letters for drug names
ISMP is planning to come up with a list of suggestions for tall man letters to differentiate look-alike drug names.
Does the use of tall man lettering (mixed case) help reduce drug name confusion, as when look-alike drugs are listed in computer databases? That’s what the Institute for Safe Medication Practices wants to find out. It has prepared a survey on its Web site to solicit pharmacists’ opinions. ISMP said the findings will be used to prepare an unofficial list of look-alike drug name pairs with suggested tall man letters to guide practitioners and healthcare organizations. ISMP cautioned that this will not be an FDA-approved list. Tall man letters on package labels will still require Food & Drug Administration approval. Responses to the survey are sought by June 27.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
